NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2024. All Rights Reserved.
Date: Friday, April 19, 2024 2:54

Description: Zoetis logo
Release 7.39
Vanguard Lepto ci
 
Species: Dogs
Therapeutic indication: Immunological veterinary medical products: For dogs
Active ingredient: Vaccine Antigens
Product:Vanguard® Lepto Ci
Product index: Vanguard Lepto Ci
Incorporating:
Presentation
A solution for injection, each 1 ml dose containing inactivated Leptospira canicola (between 420 and 740 RU (Relative Units)) and inactivated Leptospira icterohaemorrhagiae (between 463 and 915 RU).
Uses
For the active immunisation of healthy dogs and puppies to reduce clinical signs caused by Leptospira canicola and Leptospira icterohaemorrhagiae.
Onset of immunity occurs by approximately 2 weeks after the last dose of the Basic Vaccination Scheme.
The duration of immunity is at least 12 months.
Dosage and administration
Shake well and immediately inject the entire contents of the vial (1 ml) subcutaneously. Do not use chemically sterilized syringes or needles, as these will interfere with the effectiveness of the vaccine.
Basic Vaccination Scheme
Puppies younger than 10 weeks of age
Two doses of Vanguard Lepto ci at least 14 days apart. The first dose can be given as young as 7 weeks of age. The second dose should not be given until at least 10 weeks of age.
Puppies 10 weeks of age and older
Two doses of Vanguard Lepto ci at least 14 days apart.
Re-vaccination Scheme
A single dose of Vanguard Lepto ci to be given annually thereafter.
Contra-indications, warnings, etc
Do not vaccinate unhealthy or pregnant animals.
Safety and efficacy data are available which demonstrate that this vaccine can be mixed and administered with veterinary medicinal products from the Vanguard range containing canine distemper virus, canine parvovirus, canine adenovirus or canine parainfluenza virus or administers on the same day at different injection sites.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the products mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to me made on a case by case basis.
On very rare occasions, vaccinated dogs may have a transient swelling (up to 3 cm) 4-6 hours after vaccination which resolves after approximately 7 days. Very rarely, if a systemic anaphylactic reaction occurs (e.g. vomiting) administer appropriate systematic treatment (e.g. adrenaline or an equivalent).
Occasional transient swellings may occur at the injection site after vaccination with an overdose. No treatment is necessary in most cases of overdose. However, if a systemic anaphylactic reaction occurs (e.g. vomiting) administer adrenaline or an equivalent.
User warning:
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Pharmaceutical precautions
Store and transport refrigerated at +2°C to +8°C. Do not freeze.
For animal treatment only.
Keep out of the sight and reach of children.
Legal category
Legal category: POM-V
Packaging quantities
Packs contain 25 doses of Vanguard Lepto ci. Packs of disposable syringes and needles are also available.
Disposal:
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
Marketing Authorisation Number
Vm 42058/4161
Significant changes
GTIN
GTIN description:25 x 1 dose:
GTIN:05013457077360